0001178913-23-003300.txt : 20231010 0001178913-23-003300.hdr.sgml : 20231010 20231010160535 ACCESSION NUMBER: 0001178913-23-003300 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231010 FILED AS OF DATE: 20231010 DATE AS OF CHANGE: 20231010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRINITY BIOTECH PLC CENTRAL INDEX KEY: 0000888721 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22320 FILM NUMBER: 231317976 BUSINESS ADDRESS: STREET 1: IDA BUSINESS PARK, BRAY, CO WICKLOW STREET 2: IRELAND CITY: DUBLIN IRELAND STATE: L2 ZIP: 18 BUSINESS PHONE: 01135312955111 MAIL ADDRESS: STREET 1: 3 ROCK ROAD STREET 2: SANDYFORD INDUSTRIAL ESTATES CITY: DUBLIN IRELAND STATE: L2 ZIP: 18 6-K 1 zk2330357.htm 6-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549


F O R M 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2023

TRINITY BIOTECH PLC
(Name of Registrant)

IDA Business Park
Bray, Co. Wicklow, Ireland
 (Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐      

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):          

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):          

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐    No ☒

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-               

This Form 6-K is being incorporated by reference into our Registration Statements on Form S-8 (File Nos. 333-182279, 333-195232 and 333-253070) and Registration Statements on Form F-3 (File Nos. 333-239701, 333-264992 and 333-267160).

Trinity Biotech plc Announces Results of Annual General Meeting
 
At the recent Annual General Meeting of the Company shareholders approved the following resolutions (as more fully set out in the Notice of AGM dated September 4, 2023):
 

1.
To re-appoint Grant Thornton as statutory auditor of the Company to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company.
 
2.
To authorise the board of directors to fix the statutory auditors' remuneration.
 
4.
To elect Dr Andrew Omidvar as a director.
 
Resolution 3, which sought to re-elect Thomas Lindsay as a director (who retired at the Annual General Meeting) was not approved by the requisite majority of shareholders who voted.
 
After the AGM, the Board of Directors resolved to appoint Mr. Lindsay as a director of the Company on an interim basis until the next Annual General Meeting given, amongst other reasons, the obligation of the Company to maintain an independent audit committee, which is a role Mr. Lindsay fulfills.
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
TRINITY BIOTECH PLC
  
   
Trinity Biotech plc
  
   
(Registrant)
  
       
 
By:
/s/ Aris Kekedjian
  
   
Aris Kekedjian
  
   
Chairman
  

Date:  October 10, 2023